Хайлтын үр дүнгүүд - Peyrin-Biroulet, L

Does hyperhomocysteinaemia contribute to gastric carcinogenesis in Helicobacter pylori infected patients? -н Peyrin‐Biroulet, L, Guéant, Jean‐Louis

Бүрэн текст авах Бүрэн текст авах

Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD -н Sebastian, S, Gonzalez, H A, Peyrin-Biroulet, L

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

PPARγ as a new therapeutic target in inflammatory bowel diseases -н Dubuquoy, L, Rousseaux, C, Thuru, X, Peyrin‐Biroulet, L, Romano, O, Chavatte, P, Chamaillard, M, Desreumaux, P

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona... -н Colombel, J.‐F., Jharap, B., Sandborn, W. J., Feagan, B., Peyrin‐Biroulet, L., Eichner, S. F., Robinson, A. M., Mostafa, N. M., Zhou, Q., Thakkar, R. B.

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce -н Magro, F, Rahier, J-F, Abeu, C, MacMahon, E, Hart, A, van der Woude, C J, Gordon, H, Adamina, M, Viget, N, Vavricka, S, Kucharzik, T, Leone, S, Siegmund, B, Danese, S, Peyrin-Biroulet, L

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method -н Reinisch, W, Chowers, Y, Danese, S, Dignass, A, Gomollón, F, Haagen Nielsen, O, Lakatos, P L, Lees, C W, Lindgren, S, Lukas, M, Mantzaris, G J, Michetti, P, Moum, B, Peyrin-Biroulet, L, Toruner, M, Woude, J, Weiss, G, Stoevelaar, H

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease -н Marthey, L., Mateus, C., Mussini, C., Nachury, M., Nancey, S., Grange, F., Zallot, C., Peyrin-Biroulet, L., Rahier, J. F., Bourdier de Beauregard, M., Mortier, L., Coutzac, C., Soularue, E., Lanoy, E., Kapel, N., Planchard, D., Chaput, N., Robert, C., Carbonnel, F.

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY -н Peyrin-Biroulet, L, Loftus, E V, Danese, S, Vermeire, S, Sandborn, W J, Fogel, R, Nijhawan, S, Kempinski, R, Filip, R, Hospodarskyy, I, McNally, J, Yun, C, Zhao, S, Liu, X, Tasset, C, Besuyen, R, Watanabe, M, Schreiber, S, Rogler, G, Hibi, T, Feagan, B G

Бүрэн текст авах Бүрэн текст авах

A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY -н Panaccione, R, Ferrante, M, Feagan, B G, Sandborn, W, Panes, J, Peyrin-Biroulet, L, Colombel, J, Schreiber, S, Dubinsky, M, Baert, F, Hisamatsu, T, Neimark, E, Huang, B, Liao, X, Song, A, Berg, S, Duan, W, Pang, Y, Pivorunas, V, Kligys, K, Wallace, K, D’Haens, G

Бүрэн текст авах Бүрэн текст авах